Elevated hCG outside of pregnancy - Diagnostic considerations and laboratory evaluation

Obstetrical and Gynecological Survey

Volumn 62, Issue 10, 2007, Pages 669-674

  Olsen, Tandy G ^a,b,c   Barnes, Amy A ^b   King, Jeremy A ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b San Antonio Uniformed Services Health Education Consortium   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; GONADORELIN; ORAL CONTRACEPTIVE AGENT; TUMOR MARKER;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANTIBODY LABELING; BIOASSAY; BIOLOGICAL ACTIVITY; BLADDER CANCER; CANCER DIAGNOSIS; CHORIOCARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FALSE POSITIVE RESULT; GONADOTROPIN BLOOD LEVEL; HUMAN; HYPOPHYSIS; LABORATORY DIAGNOSIS; LIVER CANCER; LUMINESCENCE; LUNG CANCER; PANCREAS CANCER; PHANTOM; PREGNANCY; RADIOACTIVITY; REVIEW; STOMACH CANCER; TROPHOBLASTIC TUMOR; UTERUS CANCER; WEIGHT REDUCTION;

CHORIONIC GONADOTROPIN; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOASSAY; NEOPLASMS; PITUITARY GLAND; TROPHOBLASTIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS; WEIGHT LOSS;

EID: 34848924677     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000281556.13788.61     Document Type: Review

References (27)

1. Cole LA. Phantom hCG and phantom choriocarcinoma. Gynecol Oncol 1998;71:325-329.
2. Rotmensch S, Cole LA. False diagnosis and needless therapy of presumed malignant disease in women with false positive human chorionic gonadotropin concentrations. Lancet 2000;355:712-715.
3. Olsen TG, Hubert PR, Nycum LR. Falsely elevated human chorionic gonadotropin leading to unnecessary therapy. Obstet Gynecol 2001;98:843-845.
4. Avoiding inappropriate clinical decisions based on false-positive human chorionic gonadotropin test results. ACOG Committee Opinion No. 278. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:1057-1059.
5. Cole LA. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem 1997;43:2233-2243.
6. Review Criteria for Assessment of Professional Use Human Chorionic Gonadotropin (hCG) In Vitro Diagnostic Devices (IVDs). Available at: http://www.fda.gov/cdrh/ode/phcg.html. Accessed June 27, 2006.
7. Mehra R, Huria A, Gupta P, et al. Choriocarcinoma with negative urinary and serum beta human chorionic gonadotropin (β HCG): a case report. Indian J Med Sci 2005;59:12.
8. Vladutiu AO, Sulewski JM, Pudlak KA, et al. Heterophilic antibodies interfering with radioimmunoassay. JAMA 1982;248:2489-2490.
9. Cole LA, Kohorn E, Smith HO. Gestation Trophoblastic Diseases: management of cases with persistent low human chorionic gonadotropin results. Obstet Gynecol Clin North Am 2005;32:615-626.
10. Odell WD, Griffin J. Pulsatile secretion of human chorionic gonadotropin in normal adults. N Engl J Med 1987;317:1688-1691.
11. Stenman UH, Alfthan H, Ranta T, et al. Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin- releasing hormone and sex steroids. J Clin Endocrinol Metab 1987;64:730-736.
12. Hoermann R, Spoettl G, Moncayo R, et al. Evidence for the presence of human chorionic gonadotropin (hCG) and free β-Subunit of hCG in the human pituitary. J Clin Endocrinol Metab 1990;71:179-186.
13. Odell WD, Griffin J, Bashey HM, et al. Secretion of chorionic gonadotropin by cultured human pituitary cells. J Clin Endocrinol Metab 1990;71:1318-1321.
14. Hammond E, Griffin J, Odell WD. A chorionic gonadotropin-secreting human pituitary cell. J Clin Endocrinol Metab 1991;72:747-754.
15. van Strien A, van Wezenbeek P. Presence of β-hCG mRNA in the human pituitary. Nucleic Acids Res 1989;17:5406.
16. Snyder JA, Haymond S, Parvin CA, et al. Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. Clin Chem 2005;51:1830-1835.
17. Greenway FL, Bray GA. Human chorionic gonadotropin (hCG) in the treatment of obesity - a critical assessment of the Simeons method. West J Med 1977;127:461-463.
18. Bray GA, Greenway FL. Current and potential drugs for the treatment of obesity. Endocr Rev 1999;20:805-875.
19. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia PA: Lippincott Williams & Wilkins, 2005.
20. Cole LA, Khanlian SA. Inappropriate management of women with persistent low hCG results. J Reprod Med 2004;49:423-432.
21. Khanlian SA, Smith HO, Cole LA. Persistent low levels of human chorionic gonadotropin: a premalignant gestational trophoblastic disease. Am J Obstet Gynecol 2003;188:1254-1259.
22. Fan C, Goto S, Furuhashi Y, et al. Radioimmunoassay of the serum free β-subunit of human chorionic gonadotropin in trophoblastic disease. J Clin Endocrinol Metab 1987;64:313-318.
23. Berkowitz R, Ozturk M, Goldstein D, et al. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Obstet Gynecol 1989;74:212-216.
24. Cole LA, Butler SA, Khanlian SA, et al. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 2006;102:151-159.
25. Cole LA, Khanlian SA, Muller CY, et al. Gestational trophobastic diseases: 3. Human chorionic gonadotropin-free-β-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 2006;102:160-164.
26. Marcillac I, Troalen F, Bidart JM, et al. Free human chorionic gonadotropin β subunit in gonadal and nongonadal neoplasma. Cancer Res 1992;52:3901-3907.
27. Khanlian S, Cole LA. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin. J Reprod Med 2006;51:812-818.